Albert Vanderlaan is a partner in Orrick’s Capital Markets and Technology Companies Groups. He works with public and private companies, SPACs, SPAC sponsors, venture capital firms and investment banks focused on the life sciences and high-growth technology sectors.
Albert is involved in a broad range of corporate legal engagements for high growth technology companies, including venture financings, public offerings, private and public company securities law compliance matters, de-SPAC transactions, SPAC IPOs, public company disclosure obligations, mergers and acquisitions and COVID-19 related matters (including public company disclosure obligations and Paycheck Protection Act eligibility and compliance matters) . He also regularly advises private and public companies and their board of directors on corporate governance issues.
Albert's clients include private and public companies in the life sciences (including, among others, immuno-oncology, gene therapy, restorative cell therapy and medical device companies), real estate, finance, automotive and Internet related industries. He also represents underwriters in initial public offerings, follow-on offerings and PIPE offerings and venture capital firms in a variety of investment transactions.
Albert was named to the Deal’s Top Rising Stars 2021 list, which recognizes top new partners at U.S. law firms who are “doing spectacular work in the field of deal-making and who have continued to progress in their career despite the obstacles put in front of them.”